Christian Becker Selected Research

Christian Becker Research Topics

Disease

25	Neoplasms (Cancer) 02/2024 - 02/2002
9	Inflammation (Inflammations) 01/2023 - 02/2012
5	Thrombosis (Thrombus) 01/2022 - 01/2009
5	Melanoma (Melanoma, Malignant) 10/2021 - 08/2005
4	Endometriosis 04/2024 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 09/2015
3	Fibrosis (Cirrhosis) 10/2019 - 08/2007
3	Hypertension (High Blood Pressure) 01/2018 - 09/2011
3	Carcinoma (Carcinomatosis) 01/2018 - 02/2002
3	Infections 07/2017 - 02/2005
3	Idiopathic Generalized Epilepsy 11/2003 - 04/2002
2	Pain (Aches) 04/2024 - 01/2013
2	Body Weight (Weight, Body) 01/2023 - 02/2002
2	Obesity 01/2023 - 01/2018
2	Heart Failure 01/2022 - 01/2022
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2016
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2016 - 01/2014
2	Hypersensitivity (Allergy) 08/2013 - 01/2012
2	Multiple Sclerosis 01/2013 - 06/2005
2	Ciliopathies 12/2011 - 04/2008
2	Nephrotic Syndrome (Syndrome, Nephrotic) 05/2011 - 12/2006
2	Poisoning 10/2010 - 06/2007
2	Juvenile Myoclonic Epilepsy 11/2003 - 04/2002
1	Dyspareunia 04/2024
1	Dysmenorrhea (Menstrual Pain) 04/2024
1	Constipation 04/2024
1	Pelvic Pain 04/2024
1	Residual Neoplasm 02/2024
1	Hypercholesterolemia 01/2023
1	type 3 Bartter syndrome 01/2023
1	Reinfection 01/2023
1	Adenocarcinoma 10/2022
1	Brain Ischemia (Cerebral Ischemia) 06/2022
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 06/2022
1	Atrial Fibrillation 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Macular Degeneration (Age-Related Maculopathy) 01/2022
1	Atypical Hemolytic Uremic Syndrome 01/2022
1	Stroke (Strokes) 10/2021

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2005
9	AntigensIBA 01/2023 - 01/2005
5	CytokinesIBA 01/2023 - 01/2005
4	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 06/2005
4	Biomarkers (Surrogate Marker)IBA 02/2018 - 01/2015
4	Angiotensin IIIBA 01/2018 - 09/2011
3	ErbB Receptors (EGF Receptor)IBA 10/2020 - 09/2015
3	Odorant Receptors (Odorant Receptor)IBA 01/2018 - 01/2013
3	Neoplasm Antigens (Tumor Antigens)IBA 09/2013 - 01/2005
3	EnzymesIBA 06/2012 - 08/2004
3	Immunoglobulin E (IgE)IBA 11/2003 - 04/2002
2	LipidsIBA 01/2023 - 01/2018
2	Chloride Channels (Chloride Channel)IBA 01/2023 - 01/2011
2	LeptinIBA 01/2023 - 01/2018
2	Interleukin-2 (IL2)IBA 01/2020 - 01/2019
2	InterferonsIBA 10/2019 - 12/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019 - 09/2011
2	MicroRNAs (MicroRNA)IBA 02/2018 - 02/2013
2	CD40 Ligand (CD40L)IBA 01/2018 - 11/2013
2	ORALIT (ORS)IBA 01/2018 - 01/2018
2	ChemokinesIBA 12/2016 - 02/2013
2	Peptides (Polypeptides)IBA 01/2015 - 02/2014
2	AllergensIBA 02/2012 - 09/2006
2	Organophosphorus CompoundsIBA 10/2010 - 06/2007
2	AntibodiesIBA 05/2008 - 08/2005
2	Transcription Factors (Transcription Factor)IBA 08/2007 - 06/2006
2	Retinaldehyde (Retinal)IBA 06/2007 - 06/2006
2	Angiogenesis InhibitorsIBA 04/2003 - 02/2002
1	Analgesics (Analgesic Drugs)IBA 04/2024
1	linzagolixIBA 04/2024
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2024
1	Norethindrone Acetate (Norlutate)FDA LinkGeneric 04/2024
1	Insulin (Novolin)FDA Link 01/2023
1	Leptin ReceptorsIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	PAR-2 ReceptorIBA 12/2022
1	HaptensIBA 12/2022
1	Peptide Hydrolases (Proteases)FDA Link 12/2022
1	ochratoxin AIBA 10/2022
1	Ribosomal DNA (rDNA)IBA 10/2022
1	Serum AlbuminIBA 06/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Thromboplastin (Tissue Factor)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	polypyrroleIBA 10/2021
1	PolymersIBA 10/2021
1	Cyclic NucleotidesIBA 10/2021
1	Adenosine Monophosphate (AMP)IBA 10/2021
1	MicellesIBA 10/2021

Therapy/Procedure

13	Therapeutics 04/2024 - 04/2003
3	Immunotherapy 01/2020 - 08/2010
2	Ligation 01/2022 - 01/2014
2	Secondary Prevention 12/2020 - 06/2014
2	Aftercare (After-Treatment) 10/2016 - 02/2002
2	Intravenous Injections 01/2015 - 02/2002
1	Prostatectomy (Retropubic Prostatectomy) 10/2022